Degenerative Disc Disease - Pipeline Insights Report - ResearchAndMarkets.com
Aug. 22, 2018
DUBLIN--(BUSINESS WIRE)--Aug 22, 2018--The "Degenerative Disc Disease - Pipeline Insights" drug pipelines has been added to ResearchAndMarkets.com's offering.
Degenerative Disc Disease - Pipeline Insights provides comprehensive insights about pipeline drugs across this indication. This report further provides information on the therapeutic development of more than 10+ pipeline drugs at various stages covering Phase II, Phase I, Pre-clinical and Discovery therapeutics and contains a comparative assessment by monotherapy, route of administration and molecule type. The report further features the dormant products for this indication. Leading companies in this space are Bone Therapeutics, Yuhan Corporation, BioRestorative Therapies and AnGes,.
Comparative analysis of pipeline drugs at various stages and their therapeutic assessment by product type and molecule type provides additional and vital details of the pipeline drugs. Information on various technologies involved in the development of pipeline therapeutics along with all the collaborations and agreements of the respective company brings added the advantage of this report. Patent and Financing details related to the products are also provided.
Companies MentionedBone Therapeutics BioRestorative Therapies TETEC Yuhan Corporation AnGes BiologicsMD DiscGenics Biopharm TissueGene
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/kb8l6z/degenerative_disc?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180822005606/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Musculoskeletal Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/22/2018 02:31 PM/DISC: 08/22/2018 02:31 PM